-10% 🎉 for following me on Instagram! 
Tumor markers in bowel cancer: what the patient needs to know
Intestinal cancer is one of the most dangerous forms of cancer, which is often detected in the late stages. For timely diagnosis and monitoring of treatment, tumor markers are actively used - special substances that are detected in the blood or other biological fluids during the development of the tumor process.
The most important tumor markers in bowel cancer
CEA (carcinoembryonic antigen)
The main marker for monitoring colorectal cancer. Its increase often indicates the presence of a tumor in the colon or rectum. However, it can also be increased in smoking, cirrhosis, pancreatitis, so it is always taken into account comprehensively.
CA 19-9
Although this marker is more commonly used in pancreatic cancer, it also provides valuable information in colorectal cancer, especially in combination with other markers.
CA 242
A more specific marker for the intestine. Can detect tumors at an early stage and helps avoid false positive results typical of CA 19-9.
TPS (tissue polypeptide-specific antigen)
Shows the rate of cell division. Often increases in aggressive forms of tumors. Its level is used to monitor treatment.
mSEPT9 (methylated SEPT9 gene)
An innovative non-invasive PCR test that detects colorectal cancer from a blood sample. Its sensitivity in early stages makes it a promising screening tool.
When to take tumor markers
Tumor markers are not prescribed to all patients, but only in specific situations:
if you have symptoms that may indicate bowel cancer (blood in the stool, change in bowel frequency, pain);
to assess the effectiveness of chemotherapy or surgery;
after treatment to detect relapse;
if there is a family history of colorectal cancer.
Deciphering test results
| Tumor marker | Reference value | Possible interpretations |
|---|---|---|
| CEA | < 5 ng/ml (non-smokers) | bowel, lung, breast cancer |
| CA 19-9 | < 37 U/ml | gastrointestinal, liver, gallbladder cancer |
| CA 242 | < 20 U/ml | colorectal cancer, pancreatic cancer |
| TPS | < 80 U/L | fast-growing intestinal tumors |
| mSEPT9 | negative | positive — probable tumor |
Limitations and caveats
Tumor markers are not an independent diagnostic method, but a supplement to colonoscopy, biopsy, or CT scan.
Normal values do not rule out the presence of an early stage tumor.
The increase can be caused by non-oncological causes - inflammation, liver disease, even stress.
Overview of current research
According to European Society for Medical Oncology (ESMO), application CEA is appropriate for dynamic surveillance after surgery. Recent studies demonstrate the effectiveness of the mSEPT9 test as a safe screening method, especially for patients who do not want to undergo colonoscopy.
Tumor markers are an important element in the overall diagnosis of bowel cancer. They do not replace instrumental methods, but they allow doctors to act quickly and accurately, especially in high-risk cases or after treatment. Consult a specialist at the first suspicions - early detection gives a chance for a full recovery.
